# China NMPA Drug Inspection - Zhejiang Huahai Pharmaceutical Co., Ltd. - Amoxicillin-clavulanate potassium capsules (4:1)

Source: https://www.globalkeysolutions.net/records/china_drug_inspection/zhejiang-huahai-pharmaceutical-co-ltd/9f0126c5-e218-4eb7-b450-5ff8993843b8/
Source feed: China

> China NMPA drug inspection for Zhejiang Huahai Pharmaceutical Co., Ltd. published October 19, 2018. Drug: Amoxicillin-clavulanate potassium capsules (4:1). 

---

## Details

- Record Type: CHINA_DRUG_INSPECTION
- Title: Jiangxi Province 2018 No. 7 Drug Supervision and Sampling Inspection Information Announcement
- Company Name: Zhejiang Huahai Pharmaceutical Co., Ltd.
- Publication Date: 2018-10-19
- Drug Name: Amoxicillin-clavulanate potassium capsules (4:1)
- Inspection Finding: Compliant

Company: https://www.globalkeysolutions.net/companies/zhejiang-huahai-pharmaceutical-co-ltd/77f8f66f-ca2e-4b91-b460-a4bd2041c866/